Adlyfe Inc. develops innovative diagnostic technologies that can detect fatal brain diseases in the blood before symptoms occur. 

Apieron is developing a noninvasive monitor to measure exhaled nitric oxide for managing inflammation and controlling the underlying disease of asthma.

Cylex diagnostics have transformed the ability of doctors to measure immune system functioning.

Dexcom is tackling the diabetes epidemic by developing sensors that wirelessly transmit glucose readings to patients and theirs doctors.

Immunicon is developing proprietary cell- and molecular-based human diagnostic products with an initial focus on cancer disease management.

Nellcor introduced the first clinically and commercially viable pulse oximeter and has grown to become the world’s foremost supplier of pulse oximetry.

Transoma Medical is a leading provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease.